ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
201
| 63.69299
| 1
|
female
| 0
| 9
| 117
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 0
| 46,112
| 24,669.1562
| null | 25.5
|
white
| 27
| 40
| 0.746948
| 0.601929
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 52
| 10.699219
| 122
| 32
| 39.09375
| null | null | null | 0.899902
| 134
| null | null | null | null | 3
| 3
|
SIP>=30
| 3
|
202
| 62.185
| 1
|
female
| 0
| 18
| 1,780
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 35,575
| 23,257.5938
| null | 9
|
black
| 4
| 9
| 0.889893
| 0.748901
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 18
| 86
| 7.699219
| 60
| 18
| 37.19531
| null | 4.399414
| 0.199982
| 0.899902
| 140
| null | null | null | null | null | null | null | 2.390625
|
203
| 53.52197
| 0
|
female
| 0
| 9
| 1,874
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 9
| 20,893
| 12,010.2578
| null | 10.5
|
white
| 24
| 36
| 0.846924
| 0.747925
| 2
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 9
| 92
| null | 112
| 36
| 37.5
| 174.96875
| 3.299805
| 0.299988
| 0.699951
| 139
| 7.369141
| null | null | null | null | null |
no(M2 and SIP pres)
| 4.283203
|
204
| 23.39999
| 1
|
female
| 1
| 96
| 96
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 26
| 943,804
| 473,212.25
| null | 28.5
|
hispanic
| 30
| 42
| 0.719971
| 0.633911
| 36
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 96
| 87
| 5.199219
| 144
| 45
| 37.29688
| 335
| 3
| 4.099609
| 1.199951
| 130
| 7.469727
| null | null | null | null | 0
|
Coma or Intub
| 0
|
205
| 65.60999
| 1
|
female
| 0
| 7
| 279
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 25,467
| 13,346.1172
| null | 11.5
|
white
| 34.796875
| 38
| 0.562988
| 0.367981
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 94
| 7.399414
| 140
| 24
| 35.79688
| 390.4375
| null | null | 2.699707
| 122
| 7.479492
| null | null | null | 0
| 2
|
SIP>=30
| 2
|
206
| 70.28094
| 1
|
male
| 1
| 14
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 28,159
| 15,654.1641
| null | 9.666664
|
white
| 27.398438
| 40
| 0.557983
| 0.362
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 14
| 106
| 10.398438
| 74
| 20
| 37
| null | 3.099609
| 4.699219
| 3
| 129
| null | null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
|
207
| 60.71997
| 1
|
male
| 1
| 4
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 63,858
| 32,674.75
| null | 48
|
white
| 39
| 53
| 0.317993
| 0.203979
| 12
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 4
| 47
| 14.798828
| 80
| 14
| 35.79688
| 135
| 2.599609
| 1.899902
| 4
| 138
| 7.30957
| null | null | null | null | null |
<2 mo. follow-up
| 2.666504
|
208
| 77.00494
| 1
|
female
| 0
| 11
| 40
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 15,565
| 10,120.9297
| null | 8
|
white
| 13.898438
| 20
| 0.888916
| 0.813965
| 1
| 1
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 11
| 99
| 8.599609
| 80
| 24
| 36.5
| null | null | null | 1
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.014648
|
209
| 42.05298
| 1
|
male
| 0
| 9
| 149
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 24,897
| 14,291.5391
| null | 15
|
hispanic
| 13.798828
| 22
| 0.946899
| 0.909912
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 9
| 62
| 10.099609
| 120
| 24
| 36.79688
| null | 4.5
| 1
| 1.299805
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
210
| 60.75
| 1
|
female
| 1
| 6
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 254,366
| 144,957.75
| null | 47
|
asian
| 40.59375
| 71
| 0.369995
| 0.251953
| 9
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 63
| 17.5
| 150
| 32
| 38.69531
| 89
| 2.899902
| 7.099609
| 2.299805
| 139
| 7.30957
| null | null | null | null | null |
<2 mo. follow-up
| 2.524902
|
211
| 71.28796
| 1
|
male
| 1
| 5
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 15
| null | 0
| 4,854
| 3,407.7559
| null | 6
|
white
| 23.5
| 36
| 0.795898
| 0.671997
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 63
| 7.299805
| 82
| 12
| 36.19531
| null | null | null | 1.699951
| 127
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
212
| 22.66899
| 1
|
female
| 0
| 9
| 101
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 15
| null | 0
| 18,751
| 10,188.0078
| null | 16
|
hispanic
| 51.695313
| 47
| 0.464966
| 0.262939
| 1
| 0
| 0
|
no
| 0.6
| 0.2
|
no dnr
| 9
| 35
| 6.699219
| 115
| 40
| 36.39844
| 175.5
| null | null | 1.299805
| 117
| 7.5
| null | null | null | 4
| null |
adl>=4 (>=5 if sur)
| 3.183199
|
213
| 59.12399
| 0
|
female
| 0
| 9
| 1,867
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 0
| 43,164
| 22,028.3438
| null | 24
|
white
| 27.699219
| 56
| 0.756958
| 0.679932
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 57
| 17.699219
| 156
| 14
| 37.5
| 170
| 3.099609
| 1.299805
| 1.5
| 140
| 7.299805
| null | null | null | null | 7
| null | 7
|
214
| 63.896
| 0
|
male
| 0
| 55
| 1,867
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 227,392
| 139,701.25
| null | 21.5
|
hispanic
| 21.898438
| 45
| 0.734985
| 0.584961
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 55
| 72
| 8.599609
| 105
| 18
| 38.39844
| 338.0625
| 2.399902
| 9
| 1
| 135
| 7.469727
| null | null | null | 3
| 5
|
SIP>=30
| 5
|
215
| 87.43097
| 1
|
male
| 1
| 16
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 89,889
| 43,052.125
| null | 31.333328
|
white
| 37.5
| 49
| 0.334961
| 0.148987
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 14
| 75
| 13.398438
| 135
| 8
| 37.79688
| 138
| null | null | 3.199707
| 125
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 3.553711
|
216
| 78.89899
| 0
|
male
| 0
| 22
| 1,863
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 40,247
| 22,146.5
| null | 10.333328
|
white
| 15.5
| 21
| 0.848999
| 0.751953
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 22
| 94
| 8.798828
| 75
| 26
| 36.5
| 326.0625
| null | null | 0.899902
| 139
| 7.329102
| null | null | null | 2
| 0
| null | 0
|
217
| 83.64099
| 0
|
male
| 0
| 12
| 1,862
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 9
| 25,653
| 14,852.3984
| null | 14.5
|
white
| 25.5
| 55
| 0.670898
| 0.498962
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 12
| 63
| 10.699219
| 62
| 28
| 39.39844
| 214.28125
| null | 1
| 2.5
| 131
| 7.439453
| null | null | null | 1
| 1
| null | 1
|
218
| 47.737
| 0
|
female
| 0
| 116
| 1,861
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 592,486
| 298,585.25
| null | 45.5
|
black
| 50.59375
| 79
| 0.237
| 0.135986
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 116
| 47
| 13.099609
| 164
| 31
| 39.29688
| 52
| null | null | 3
| 130
| 7.139648
| null | null | null | null | 1
|
Coma or Intub
| 1
|
219
| 78.84998
| 0
|
female
| 0
| 9
| 1,860
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 9,914
| 6,578.9141
| null | 7
|
black
| 10.398438
| 38
| 0.910889
| 0.849976
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 114
| 8.398438
| 78
| 20
| 37.79688
| 328.5625
| 3.899902
| 0.799927
| 1.299805
| 137
| 7.459961
| null | null | null | 4
| 6
|
SIP>=30
| 6
|
220
| 51.18399
| 0
|
male
| 0
| 10
| 1,860
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 6
|
under $11k
| 0
| 22,621
| 13,689.9297
| null | 17.5
|
black
| 21.296875
| 14
| 0.875977
| 0.793945
| 2
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 88
| 7
| 80
| 18
| 36.69531
| null | null | 3.5
| 1.099854
| 126
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
|
221
| 61.45398
| 1
|
male
| 0
| 16
| 523
|
Colon Cancer
|
Cancer
| 1
| 30
|
>$50k
| 0
| 60,175
| 33,484.4375
| null | 17.666656
|
white
| 15.599609
| 24
| 0.840942
| 0.650879
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 16
| 102
| 12.898438
| 90
| 20
| 37
| null | 3.599609
| 0.5
| 1.5
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.055664
|
222
| 55.20297
| 1
|
male
| 0
| 3
| 1,285
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 15
|
under $11k
| 0
| 3,035
| 2,104.1055
| null | 3
|
other
| 14.599609
| 16
| 0.924927
| 0.873901
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 3
| 93
| 11.199219
| 74
| 24
| 36
| null | 3.899902
| 0.699951
| 1.299805
| 136
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
223
| 74.06396
| 0
|
male
| 0
| 11
| 1,859
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 44,728
| 25,857.0625
| null | 22
|
white
| 22.796875
| 20
| 0.767944
| 0.69397
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 115
| 10
| 95
| 12
| 37.5
| 113.84375
| null | null | 1.099854
| 135
| 7.449219
| null | null | null | null | null | null | 2.402832
|
224
| 90.90796
| 1
|
female
| 1
| 17
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 69,364
| 35,313.4375
| null | 21.333328
|
white
| 19
| 24
| 0.790894
| 0.721924
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 13
| 133
| 16.296875
| 115
| 9
| 38.5
| 372.5
| 2.799805
| null | 1
| 137
| 7.399414
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
|
225
| 38.94897
| 1
|
male
| 1
| 24
| 24
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 9
|
$11-$25k
| 0
| 133,918
| 68,405.4375
| null | 18.333328
|
hispanic
| 35.695313
| 59
| 0.639893
| 0.458984
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 23
| 64
| 12.099609
| 102
| 18
| 36.39844
| null | 2
| 10.199219
| 2.799805
| 126
| null | null | null | null | 5
| 3
|
<2 mo. follow-up
| 3
|
226
| 65.14697
| 1
|
female
| 0
| 4
| 27
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,223
| 3,330.9004
| null | 7
|
white
| 19.199219
| 10
| 0.661987
| 0.358948
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 83
| 8.099609
| 106
| 22
| 36.39844
| null | null | null | 0.699951
| 136
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.418945
|
227
| 51.62799
| 1
|
female
| 0
| 8
| 557
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$25-$50k
| 0
| 23,146
| 13,344.6172
| null | 16
|
white
| 18.398438
| 17
| 0.906982
| 0.843994
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 8
| 65
| 15.898438
| 88
| 16
| 36.29688
| null | 4.199219
| 1
| 1.099854
| 128
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
228
| 56.20499
| 1
|
male
| 0
| 20
| 153
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 42,041
| 27,174.3594
| null | 12
|
white
| 6.5
| 12
| 0.873901
| 0.715942
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 20
| 107
| 8.199219
| 92
| 20
| 37.19531
| 304.75
| 4.199219
| 0.299988
| 0.899902
| 135
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.779785
|
229
| 65.88599
| 0
|
female
| 0
| 5
| 1,857
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 19,662
| 10,503.0391
| null | 21
|
white
| 18
| 31
| 0.823975
| 0.763916
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 5
| 61
| 8.398438
| 60
| 30
| 37
| 217.125
| 1.899902
| 0.699951
| 0.5
| 139
| 7.489258
| null | null | null | null | null | null | 2.237793
|
230
| 69.19598
| 1
|
male
| 0
| 9
| 115
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 24,859
| 14,226.4688
| null | 20.5
|
asian
| 32.398438
| 45
| 0.639893
| 0.458984
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 47
| 13.798828
| 70
| 20
| 36.79688
| 565
| 3.699707
| 0.699951
| 2.399902
| 126
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
231
| 77.74695
| 1
|
male
| 0
| 6
| 422
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 16,325
| 7,677.7969
| null | 11
|
other
| 16.796875
| 18
| 0.681885
| 0.386963
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 89
| 19.296875
| 80
| 18
| 36.89844
| null | null | 0.5
| 1.299805
| 133
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
|
232
| 80.09595
| 1
|
male
| 0
| 3
| 1,314
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 5,293
| 3,081.8906
| null | 8
|
white
| 17.097656
| 11
| 0.848999
| 0.750977
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 93
| null | 80
| 20
| 36.79688
| null | null | null | 0.699951
| 131
| null | null | null | null | 5
| 6
|
SIP>=30
| 6
|
233
| 71.54596
| 1
|
male
| 0
| 7
| 77
|
Lung Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 23,304
| 12,482.875
| null | 12
|
white
| 15.398438
| 26
| 0.692993
| 0.402954
| 3
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 120
| 3.5
| 89
| 26
| 36.89844
| 257.125
| null | 0.599976
| 1.199951
| 137
| 7.509766
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
|
234
| 60.61899
| 1
|
male
| 0
| 17
| 236
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
| null | 0
| 49,079
| 26,983.6719
| null | 16
|
white
| 22.796875
| 31
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 17
| 50
| 6.099609
| 110
| 20
| 36.79688
| null | 3.699707
| 0.399963
| 1.199951
| 135
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
|
235
| 58.478
| 1
|
male
| 0
| 4
| 896
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 3,580
| 1,780.9941
| null | 11
|
white
| 20.097656
| 36
| 0.87793
| 0.796997
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 106
| 9.099609
| 88
| 36
| 36.39844
| null | null | null | 1.899902
| 139
| null | null | null | null | null | null | null | 2.603027
|
236
| 52.67899
| 0
|
male
| 0
| 5
| 1,853
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 17,110
| 10,086.7188
| null | 21
|
asian
| 15.398438
| 27
| 0.924927
| 0.872925
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 5
| 60
| 3.599609
| 150
| 16
| 36.79688
| null | 4.099609
| 0.699951
| 1.099854
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
237
| 70.48596
| 1
|
male
| 0
| 37
| 336
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 149,983
| 76,851.75
| null | 27.5
|
white
| 19.199219
| 27
| 0.850952
| 0.799927
| 1
| 0
| 1
|
no
| null | null |
no dnr
| 37
| 62
| 14.099609
| 80
| 15
| 38.5
| 146
| 2.399902
| 0.399963
| 1.099854
| 134
| 7.449219
| null | null | null | null | null | null | 3.696777
|
238
| 50.58197
| 1
|
male
| 0
| 7
| 81
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 10
|
$25-$50k
| 0
| 9,113
| 5,367.9805
| null | 13
|
hispanic
| 20
| 38
| 0.837891
| 0.733887
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 70
| 3.599609
| 82
| 20
| 36.79688
| 385.6875
| 1.899902
| 1.799805
| 1.599854
| 128
| 7.489258
| null | null | null | 4
| null |
Coma or Intub
| 3.183199
|
239
| 25.487
| 1
|
male
| 1
| 19
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 126,732
| 61,916.2188
| null | 19.666656
|
white
| 37.59375
| 61
| 0.682983
| 0.589966
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
dnr after sadm
| 19
| 123
| 1.699951
| 100
| 48
| 38.5
| 191.8125
| 3.099609
| 9
| 2.299805
| 143
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.395508
|
240
| 88.69495
| 1
|
male
| 1
| 9
| 9
|
Coma
|
Coma
| 2
| null |
>$50k
| 89
| 24,242
| 14,263.6172
| null | 16
|
white
| 25.097656
| 41
| 0.056999
| 0.029999
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 102
| 11.599609
| 123
| 14
| 38.39844
| 397.125
| 3.099609
| 0.699951
| 5.699219
| 135
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
241
| 68.01898
| 1
|
male
| 0
| 81
| 277
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 26
| 659,433
| 324,373.75
| null | 42.25
|
white
| 32.398438
| 58
| 0.143982
| 0.067993
| 30
| 0
| 0
|
metastatic
| null | null |
no dnr
| 81
| 70
| 12.599609
| 115
| 10
| 37.5
| 218
| 2.599609
| 7.699219
| 2.799805
| 134
| 7.479492
| null | null | null | null | null | null | 3.217285
|
242
| 81.77698
| 1
|
female
| 0
| 7
| 927
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 7
| null | 0
| 5,405
| 3,686.4316
| null | 5
|
black
| 16.898438
| 32
| 0.703979
| 0.541992
| 1
| 0
| 0
|
no
| null | 0.8
|
no dnr
| 7
| 107
| 3.599609
| 92
| 26
| 36.79688
| null | 2.199707
| null | 0.699951
| 138
| null | null | null | null | 5
| 0
|
SIP>=30
| 0
|
243
| 71.86298
| 1
|
male
| 0
| 3
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 3,869
| 2,602.3711
| null | 6
|
white
| 16.398438
| 25
| 0.878906
| 0.79895
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 87
| 8.099609
| 80
| 20
| 36.09375
| 342.8125
| null | null | 1.5
| 138
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.296387
|
244
| 72.19696
| 0
|
female
| 0
| 8
| 1,849
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 9,991
| 6,090.7852
| null | 7
|
black
| 18.296875
| 34
| 0.841919
| 0.73999
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 8
| 107
| 6.699219
| 72
| 18
| 36.79688
| null | null | null | 2.299805
| 141
| null | null | null | null | null | null | null | 3.44043
|
245
| 53.40997
| 0
|
male
| 0
| 12
| 1,847
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 26
| 102,911
| 52,412.25
| null | 24
|
white
| 27.199219
| 35
| 0.653931
| 0.554932
| 9
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 12
| 113
| 25.5
| 120
| 25
| 37.29688
| 260
| 2.5
| 5.799805
| 0.799927
| 136
| 7.489258
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.511231
|
246
| 34.35699
| 1
|
male
| 1
| 8
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 26
| 110,596
| 55,677.625
| null | 51
|
hispanic
| 44.398438
| 72
| 0.305969
| 0.192993
| 9
| 0
| 0
|
no
| 0.2
| 0.008
|
no dnr
| 8
| 48
| 6.199219
| 120
| 33
| 38.5
| 150
| 2.399902
| 6
| 2.299805
| 130
| 7.30957
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
|
247
| 56.66498
| 1
|
male
| 1
| 14
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 206,651
| 102,511.375
| null | 47.666657
|
white
| 41.898438
| 81
| 0.324951
| 0.209991
| 31
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 10
| 63
| 18.597656
| 125
| 30
| 38.5
| 148
| null | 16.796875
| 4.099609
| 147
| 7.189453
| null | null | null | null | null |
<2 mo. follow-up
| 2.322754
|
248
| 53.67798
| 1
|
female
| 0
| 11
| 308
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
| null | 0
| 14,583
| 8,907.6328
| null | 9.5
|
white
| 24.796875
| 43
| 0.751953
| 0.60791
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 11
| 113
| 7.5
| 100
| 24
| 37
| null | 2
| 19.898438
| 1.299805
| 137
| null | null | null | null | 0
| 0
| null | 0
|
249
| 55.32898
| 0
|
male
| 0
| 6
| 1,845
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 11,985
| 7,751.6758
| null | 12
|
asian
| 17.898438
| 11
| 0.712891
| 0.432983
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 93
| null | 112
| 20
| 37.19531
| null | null | null | 0.899902
| 136
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
250
| 54.056
| 1
|
male
| 1
| 8
| 8
|
Coma
|
Coma
| 2
| 18
|
$25-$50k
| 55
| 46,156
| 22,832.2656
| null | 31
|
white
| 30.898438
| 53
| 0.345947
| 0.272949
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 110
| 29.597656
| 165
| 34
| 39.19531
| 223.3125
| null | 1.899902
| 1.699951
| 128
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
|
251
| 70.80396
| 1
|
male
| 1
| 19
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 37
| 222,230
| 110,654.812
| null | 40.333313
|
hispanic
| 31.199219
| 60
| 0.366943
| 0.248993
| 14
| 1
| 0
|
no
| null | null |
dnr after sadm
| 19
| 83
| 16.898438
| 135
| 34
| 39
| 296.25
| null | 12.099609
| 1.399902
| 134
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.210938
|
252
| 86.57098
| 1
|
female
| 1
| 4
| 4
|
Coma
|
Coma
| 1
| null | null | 94
| 10,662
| 5,654.9883
| null | 14
|
white
| 30.398438
| 40
| 0.003
| 0.001
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 97
| 15.099609
| 80
| 28
| 36.79688
| 24
| null | null | 1.199951
| 133
| 7.239258
| null | null | null | null | null |
<2 mo. follow-up
| 3.831543
|
253
| 52.44897
| 1
|
male
| 0
| 6
| 1,079
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 10,469
| 6,520.1992
| null | 10
|
white
| 4.399414
| 16
| 0.895996
| 0.761963
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 6
| 84
| 11.5
| 80
| 20
| 36.19531
| null | 4.5
| 0.299988
| 1
| 136
| null | null | null | null | null | 0
| null | 0
|
254
| 50.97897
| 1
|
male
| 0
| 9
| 1,600
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 27,015
| 12,740.8125
| null | 11.5
|
white
| 26.398438
| 29
| 0.830933
| 0.724976
| 5
| 0
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 9
| 122
| 9.099609
| 110
| 32
| 36.5
| 124.48438
| null | null | 0.799927
| 137
| 7.419922
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
|
255
| 77.75995
| 1
|
male
| 1
| 7
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 34,038
| 18,083.2969
| null | 27
|
white
| 16
| 37
| 0.866943
| 0.778931
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 58
| 4.899414
| 60
| 16
| 36.19531
| null | 4.299805
| null | 1.599854
| 133
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
|
256
| 54.18198
| 1
|
male
| 1
| 6
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 17
|
>$50k
| 9
| 40,620
| 20,159.0312
| null | 46
|
white
| 36
| 64
| 0.330994
| 0.215973
| 2
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 4
| 60
| 4.5
| 190
| 40
| 39.5
| 90
| 1.699951
| 0.5
| 1.199951
| 130
| 7.30957
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
|
257
| 34.17398
| 1
|
female
| 1
| 5
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
under $11k
| 26
| 39,002
| null | null | 56
|
white
| 49.296875
| 53
| 0.21698
| 0.119995
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 4
| 67
| 1.599854
| 85
| 34
| 33.89844
| 46
| null | 1.899902
| 0.299988
| 128
| 7.399414
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
|
258
| 80.52295
| 1
|
male
| 0
| 5
| 164
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,853
| 3,727.5195
| null | 8
|
white
| 17.5
| 35
| 0.842896
| 0.74292
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 97
| 7.199219
| 88
| 20
| 36.79688
| 319
| 4
| 0.699951
| 3.199707
| 136
| 7.489258
| null | null | null | null | null | null | 2.661133
|
259
| 50.53
| 1
|
male
| 0
| 6
| 1,349
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 18,574
| 11,205.3984
| null | 16
| null | 15.5
| 18
| 0.917969
| 0.861938
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 66
| 4.899414
| 80
| 24
| 36.69531
| null | null | null | 1.399902
| 134
| null | null | null | null | null | null | null | 2.05957
|
260
| 56.82397
| 1
|
female
| 0
| 15
| 699
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 49,730
| 23,862.5781
| null | 13
|
black
| 20.898438
| 15
| 0.849976
| 0.75293
| 2
| 0
| 0
|
yes
| 0.7
| 0.65
|
no dnr
| 15
| 70
| 22
| 60
| 19
| 37
| 165.6875
| null | null | 1
| 137
| 7.449219
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.105957
|
261
| 45.892
| 1
|
male
| 0
| 76
| 105
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 9
| 330,735
| null | null | 20.5
|
black
| 19.898438
| 34
| 0.835938
| 0.779907
| 54
| 0
| 0
|
no
| null | null |
no dnr
| 76
| 115
| 9.798828
| 145
| 32
| 38.69531
| 510
| 2
| 0.299988
| 0.899902
| 136
| 7.40918
| null | null | null | null | null | null | 2.686523
|
262
| 69.71698
| 1
|
female
| 1
| 4
| 4
|
Coma
|
Coma
| 2
| null | null | 100
| 21,696
| 11,611.6016
| null | 34
|
white
| 19.597656
| 25
| 0.283997
| 0.214996
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 115
| 14
| 95
| 16
| 36.39844
| 236.65625
| null | 0.399963
| 1.799805
| 141
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.983887
|
263
| 65.89996
| 1
|
male
| 0
| 20
| 693
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$11-$25k
| 26
| 143,419
| null | null | 25
|
white
| 19.5
| 50
| 0.734985
| 0.652954
| 18
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 20
| 130
| 6.699219
| 110
| 26
| 38.19531
| 365
| 2.099609
| 0.199982
| 1.199951
| 131
| 7.5
| null | null | null | 1
| null | null | 1.1669
|
264
| 38.491
| 0
|
male
| 0
| 21
| 1,821
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 111,543
| 56,904.375
| null | 22.333328
|
white
| 32
| 43
| 0.747925
| 0.667969
| 4
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 21
| 123
| 12.898438
| 125
| 38
| 39.79688
| 162
| 2.899902
| 3.399902
| 0.699951
| 134
| 7.259766
| null | null | null | null | null | null | 2.45459
|
265
| 65.53595
| 1
|
male
| 0
| 14
| 1,332
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 27
|
>$50k
| 0
| 61,126
| 30,566.9375
| null | 21.333328
|
black
| 20.597656
| 27
| 0.759888
| 0.68396
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 14
| 108
| 10.699219
| 100
| 12
| 39.29688
| 220
| 2.299805
| 0.899902
| 1.799805
| 136
| 7.40918
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.101074
|
266
| 59.146
| 1
|
male
| 0
| 10
| 585
|
Lung Cancer
|
Cancer
| 2
| 11
| null | 0
| 17,737
| 9,855.5469
| null | 10.5
|
white
| 18.699219
| 23
| 0.68689
| 0.393982
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 10
| 74
| 2.699707
| 128
| 24
| 38.89844
| null | null | 1.199951
| 0.899902
| 138
| null | null | null | null | 3
| 3
| null | 3
|
267
| 53.922
| 1
|
female
| 0
| 24
| 78
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 46,135
| 28,130.0312
| null | 12.666664
|
white
| 4.599609
| 14
| 0.93689
| 0.849976
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 24
| 83
| 10.5
| 100
| 24
| 37.39844
| null | 4.599609
| 0.399963
| 0.799927
| 135
| null | null | null | null | null | null | null | 2.050293
|
268
| 40.63199
| 0
|
male
| 0
| 13
| 1,816
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 1
|
$11-$25k
| 0
| 29,551
| 16,497.9375
| null | 17
|
hispanic
| 19.398438
| 23
| 0.920898
| 0.865967
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 13
| 95
| null | 94
| 26
| 36
| null | null | null | 1.5
| 140
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
|
269
| 65.67596
| 1
|
male
| 0
| 25
| 62
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 57,969
| 33,842.3438
| null | 10.25
|
white
| 33.695313
| 35
| 0.260986
| 0.035995
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.3
|
dnr after sadm
| 12
| 64
| 11.398438
| 134
| 32
| 38.79688
| 309.5
| 2.599609
| null | 0.799927
| 132
| 7.519531
| null | null | null | 0
| null | null | 0.4948
|
270
| 53.10098
| 1
|
male
| 1
| 4
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 15,394
| 7,895.8438
| null | 29
|
white
| 32.695313
| 35
| 0.725952
| 0.571899
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 43
| 13.298828
| 150
| 22
| 36.69531
| 610
| 3.799805
| 1.5
| 1.299805
| 132
| 7.679688
| null | null | null | null | null |
<2 mo. follow-up
| 2.807129
|
271
| 43.28299
| 1
|
female
| 1
| 7
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 100
| 100,051
| null | null | 21.5
| null | 33.898438
| 63
| 0.014
| 0.003
| 22
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 3
| 87
| 0.299988
| 140
| 44
| 38.5
| 259.125
| 2.699707
| 3.199707
| 1.5
| 146
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 3.533203
|
272
| 35.14297
| 1
|
male
| 0
| 5
| 1,131
|
Lung Cancer
|
Cancer
| 0
| 14
|
>$50k
| 0
| 7,880
| 4,021.0273
| null | 10
|
white
| 16.796875
| 13
| 0.774902
| 0.530884
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 77
| 8.298828
| 80
| 18
| 35.39844
| null | null | null | 0.899902
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
273
| 51.49899
| 1
|
female
| 0
| 4
| 28
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 5,765
| 3,633.0703
| null | 9
|
white
| 18
| 27
| 0.820923
| 0.708984
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 87
| 6.099609
| 88
| 20
| 36.59375
| 366.625
| 2.299805
| 2
| 1.199951
| 130
| 7.549805
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
|
274
| 76.44897
| 1
|
male
| 0
| 18
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 26
| 92,307
| 49,963.5
| null | 23.666656
|
white
| 24.898438
| 37
| 0.593994
| 0.484985
| 6
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 18
| 108
| 14.798828
| 140
| 20
| 39
| null | null | null | 2
| 144
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
|
275
| 81.24597
| 1
|
female
| 1
| 3
| 3
|
Coma
|
Coma
| 1
| null | null | 100
| 15,473
| 7,722.8047
| null | 43
|
white
| 24.097656
| 58
| 0.080994
| 0.046997
| 1
| 0
| 1
|
no
| 0.05
| 0.000125
|
dnr before sadm
| 0
| 58
| 8.5
| 70
| 30
| 37.5
| 178
| 2.5
| 1.5
| 2.299805
| 135
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 5.240234
|
276
| 19.60599
| 1
|
female
| 1
| 5
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 413,774
| null | null | 48
|
white
| 42.296875
| 59
| 0.56189
| 0.449951
| 40
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 48
| 6.099609
| 131
| 12
| 38.79688
| 156.25
| 4.399414
| 16.398438
| 1.099854
| 155
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 2.126465
|
277
| 63.431
| 0
|
male
| 0
| 61
| 1,809
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$11-$25k
| 26
| 409,250
| null | null | 34.5
|
white
| 31.296875
| 34
| 0.472961
| 0.353943
| 15
| 0
| 0
|
no
| null | 0.6
|
no dnr
| 61
| 90
| 3.399902
| 130
| 20
| 37.09375
| 230
| 2.799805
| 4.699219
| 2.099609
| 141
| 7.489258
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
|
278
| 52.37198
| 1
|
male
| 0
| 5
| 644
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 6,622
| 3,758.2363
| null | 11
|
black
| 14.898438
| 10
| 0.939941
| 0.897949
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 5
| 102
| 15.5
| 80
| 18
| 37
| 300
| null | null | 1
| 140
| 7.429688
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
|
279
| 38.883
| 0
|
male
| 0
| 15
| 1,807
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 37
| 34,680
| 18,825.9219
| null | 18.666656
|
hispanic
| 20
| 21
| 0.852905
| 0.802979
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 15
| 83
| 7
| 110
| 30
| 38.69531
| 257.125
| 3.599609
| 0.099991
| 0.699951
| 133
| 7.449219
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
|
280
| 77.67596
| 1
|
male
| 1
| 4
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 41
| 26,620
| 13,928.5234
| null | 39
|
white
| 40.898438
| 73
| 0.015999
| 0.003
| 4
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 38
| 10.099609
| 110
| 20
| 38.79688
| 207.6875
| null | 2.799805
| 2.099609
| 131
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 3.762695
|
281
| 75.96698
| 1
|
female
| 0
| 9
| 34
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 9
| 12,424
| 7,979.4453
| null | 7.5
|
white
| 16.796875
| 30
| 0.650879
| 0.344971
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 5
| 107
| 25.5
| 100
| 20
| 36.39844
| null | 3.899902
| null | 1.5
| 135
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
282
| 42.38699
| 1
|
female
| 1
| 12
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 221,026
| 108,952.438
| null | 35
|
white
| 40.09375
| 56
| 0.186981
| 0.097992
| 24
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 112
| 1.399902
| 70
| 18
| 36.59375
| 144
| 4.599609
| 7.5
| 3.899902
| 143
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.336914
|
283
| 47.24698
| 1
|
female
| 0
| 10
| 108
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 29,076
| 15,755.8828
| null | 27
|
asian
| 40.695313
| 44
| 0.136993
| 0.007
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 10
| 47
| 12.798828
| 140
| 32
| 38.59375
| 246.9375
| 2.599609
| 1.299805
| 1.299805
| 135
| 7.369141
| null | null | null | null | null | null | 2.960449
|
284
| 69.66699
| 1
|
male
| 1
| 14
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 122,908
| 62,152.9062
| null | 44.333313
|
white
| 29.796875
| 38
| 0.452942
| 0.251953
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 13
| 93
| 12.298828
| 150
| 14
| 37
| 142.84375
| 2.399902
| 5.399414
| 0.899902
| 138
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.55127
|
285
| 57.58197
| 1
|
male
| 0
| 10
| 1,395
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 26,110
| 15,292.6016
| null | 17.5
|
white
| 20
| 38
| 0.880981
| 0.80188
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 10
| 65
| 5
| 125
| 26
| 36.89844
| 400
| 3.899902
| 2.799805
| 1.299805
| 140
| 7.539062
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
286
| 50.64798
| 0
|
male
| 0
| 10
| 1,798
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 23,376
| 13,861.8125
| null | 21.5
|
black
| 18.5
| 28
| 0.908936
| 0.845947
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 10
| 67
| 5.299805
| 115
| 30
| 36.79688
| 419
| 3.399902
| 1.399902
| 1.199951
| 143
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
287
| 60.07898
| 1
|
male
| 0
| 11
| 800
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 22,300
| 13,441.8594
| null | 11.5
|
white
| 7.899414
| 18
| 0.911987
| 0.796997
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 11
| 103
| 4.299805
| 110
| 18
| 36.79688
| 283.3125
| 4.299805
| 0.299988
| 1.099854
| 142
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
|
288
| 67.47998
| 1
|
male
| 0
| 11
| 406
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 11,506
| 7,928.3516
| null | 11
|
white
| 9
| 24
| 0.896973
| 0.763916
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.75
|
no dnr
| 11
| 108
| 6.5
| 58
| 20
| 38.89844
| null | 4.099609
| 0.299988
| 1.5
| 143
| null | null | null | null | null | null | null | 2.262695
|
289
| 62.875
| 1
|
male
| 0
| 9
| 1,126
|
Colon Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 23,575
| 14,252.5938
| null | 8
|
white
| 7.199219
| 20
| 0.914917
| 0.80188
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 9
| 96
| 12.5
| 120
| 24
| 39
| null | 4.599609
| 0.199982
| 0.799927
| 137
| null | null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
|
290
| 74.10797
| 1
|
male
| 1
| 17
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 44
| 73,695
| 34,402.0938
| null | 26.333328
|
white
| 28.898438
| 35
| 0.462952
| 0.260986
| 1
| 0
| 1
|
no
| 0.5
| 0.4
|
dnr after sadm
| 5
| 63
| 22
| 160
| 12
| 37
| 134
| null | null | 0.599976
| 140
| 7.429688
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
|
291
| 66.73199
| 1
|
male
| 0
| 18
| 576
|
Colon Cancer
|
Cancer
| 2
| 16
|
$25-$50k
| 0
| 30,052
| 18,453.2812
| null | 11.666664
|
white
| 10.599609
| 21
| 0.884888
| 0.737915
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 18
| 110
| 9.199219
| 90
| 28
| 37.19531
| null | 3.899902
| 0.5
| 0.899902
| 140
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
|
292
| 71.39996
| 1
|
female
| 0
| 40
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 163,714
| 85,802.9375
| null | 20.25
|
white
| 26.699219
| 29
| 0.690918
| 0.598999
| 5
| 1
| 0
|
no
| null | null |
dnr after sadm
| 32
| 120
| 10.798828
| 65
| 22
| 36.59375
| 86.65625
| null | 0.5
| 1.599854
| 143
| 7.469727
| null | null | null | 5
| null |
<2 mo. follow-up
| 3.855299
|
293
| 60.85699
| 1
|
female
| 0
| 9
| 309
|
Lung Cancer
|
Cancer
| 0
| null | null | 0
| 22,052
| 13,990.0859
| null | 11
|
white
| 10.099609
| 29
| 0.826904
| 0.625
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 98
| 3.799805
| 110
| 20
| 37.5
| 196
| 4.199219
| 0.099991
| 1.099854
| 136
| 7.40918
| null | null | null | null | null | null | 2.550781
|
294
| 47.37598
| 1
|
female
| 1
| 19
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 26
| 266,998
| 128,401.812
| null | 38.333313
|
white
| 32.398438
| 52
| 0.262939
| 0.156982
| 23
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr after sadm
| 19
| 78
| 7.599609
| 130
| 25
| 39.69531
| 152
| null | 1.199951
| 4.599609
| 145
| 7.379883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
295
| 71.15094
| 1
|
female
| 1
| 13
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 10
|
$11-$25k
| 0
| 27,021
| 15,741.9766
| null | 22.5
|
black
| 23.398438
| 40
| 0.797974
| 0.674927
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 10
| 127
| 6.699219
| 110
| 24
| 37.5
| 455.5
| null | 1
| 3.5
| 140
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
|
296
| 64.24597
| 0
|
female
| 0
| 15
| 1,788
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 32,157
| 17,095.1094
| null | 12.666664
|
hispanic
| 25.796875
| 47
| 0.768921
| 0.694946
| 2
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 15
| 77
| 33.59375
| 110
| 22
| 38
| 346.625
| null | 1.599854
| 3
| 143
| 7.269531
| null | null | null | null | 1
| null | 1
|
297
| 21.63699
| 1
|
female
| 0
| 10
| 591
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 17,730
| 11,209.3672
| null | 9.5
|
white
| 19.398438
| 15
| 0.858887
| 0.685913
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.9
|
no dnr
| 10
| 88
| 17.097656
| 74
| 20
| 36.39844
| null | null | 4.199219
| 0.899902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
298
| 60.58899
| 1
|
male
| 1
| 7
| 7
|
Lung Cancer
|
Cancer
| 2
| 12
|
>$50k
| 9
| 17,989
| 10,208.0312
| null | 11.5
|
white
| 23.097656
| 26
| 0.539917
| 0.21698
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 6
| 117
| 12.398438
| 135
| 26
| 36.5
| null | null | 0.299988
| 1.099854
| 133
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
299
| 55.20599
| 1
|
female
| 0
| 13
| 829
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 28,330
| 15,057.5703
| null | 12.5
|
black
| 17.398438
| 19
| 0.918945
| 0.863892
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 13
| 93
| 5.799805
| 95
| 26
| 37.29688
| 223.3125
| null | null | 0.699951
| 142
| 7.379883
| null | null | null | 6
| 6
|
adl>=4 (>=5 if sur)
| 6
|
300
| 66.54596
| 1
|
male
| 1
| 45
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
>$50k
| 0
| 348,628
| 177,669.875
| null | 37.75
|
white
| 31.199219
| 38
| 0.565918
| 0.453979
| 27
| 0
| 0
|
no
| 0.95
| 0.95
|
dnr after sadm
| 45
| 67
| 19.699219
| 150
| 20
| 39.39844
| 182.5
| 3.799805
| 1.699951
| 1.5
| 127
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.989746
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.